125 related articles for article (PubMed ID: 37392128)
1. A Dual Stimuli-Responsive Nanoplatform Loaded Pt
Fang K; Sun Y; Yang J; Hu X; Chen M; Li R; Yang X; Fan T; Wu J; Tong X; Dong C; Shi S
Adv Healthc Mater; 2023 Nov; 12(28):e2301328. PubMed ID: 37392128
[TBL] [Abstract][Full Text] [Related]
2. Manganese-deposited iron oxide promotes tumor-responsive ferroptosis that synergizes the apoptosis of cisplatin.
Cheng J; Zhu Y; Xing X; Xiao J; Chen H; Zhang H; Wang D; Zhang Y; Zhang G; Wu Z; Liu Y
Theranostics; 2021; 11(11):5418-5429. PubMed ID: 33859755
[No Abstract] [Full Text] [Related]
3. Amorphous ferric oxide-coating selenium core-shell nanoparticles: a self-preservation Pt(IV) platform for multi-modal cancer therapies through hydrogen peroxide depletion-mediated anti-angiogenesis, apoptosis and ferroptosis.
Xu Z; Li Q; Zhang C; Wang P; Xu X; Ran L; Zhang L; Tian G; Zhang G
Nanoscale; 2022 Aug; 14(32):11600-11611. PubMed ID: 35861683
[TBL] [Abstract][Full Text] [Related]
4. A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy.
Hu X; Li R; Wu W; Fang K; Zhu Z; Wang Y; Zhou L; Chen M; Dong C; Shi S
J Control Release; 2022 Aug; 348():660-671. PubMed ID: 35716884
[TBL] [Abstract][Full Text] [Related]
5. Engineering a synergistic antioxidant inhibition nanoplatform to enhance oxidative damage in tumor treatment.
Zhang Q; Sun Z; Sun W; Yu B; Liu J; Jiang C; Lu L
Acta Biomater; 2023 Mar; 158():625-636. PubMed ID: 36608895
[TBL] [Abstract][Full Text] [Related]
6. Nano-assembly of ursolic acid with platinum prodrug overcomes multiple deactivation pathways in platinum-resistant ovarian cancer.
Wang Y; Luo Z; Zhou D; Wang X; Chen J; Gong S; Yu Z
Biomater Sci; 2021 Jun; 9(11):4110-4119. PubMed ID: 33949442
[TBL] [Abstract][Full Text] [Related]
7. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H
Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983
[TBL] [Abstract][Full Text] [Related]
8. An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance.
Ai F; Sun T; Xu Z; Wang Z; Kong W; To MW; Wang F; Zhu G
Dalton Trans; 2016 Aug; 45(33):13052-60. PubMed ID: 27430044
[TBL] [Abstract][Full Text] [Related]
9. MOF-based nanozyme grafted with cooperative Pt(IV) prodrug for synergistic anticancer therapy.
Wu PH; Cheng PF; Kaveevivitchai W; Chen TH
Colloids Surf B Biointerfaces; 2023 May; 225():113264. PubMed ID: 36921426
[TBL] [Abstract][Full Text] [Related]
10. Reduction-sensitive platinum (IV)-prodrug nano-sensitizer with an ultra-high drug loading for efficient chemo-radiotherapy of Pt-resistant cervical cancer in vivo.
Luo K; Guo W; Yu Y; Xu S; Zhou M; Xiang K; Niu K; Zhu X; Zhu G; An Z; Yu Q; Gan Z
J Control Release; 2020 Oct; 326():25-37. PubMed ID: 32531414
[TBL] [Abstract][Full Text] [Related]
11. Redox-sensitive polyglutamic acid-platinum(IV) prodrug grafted nanoconjugates for efficient delivery of cisplatin into breast tumor.
Wang R; He D; Wang H; Wang J; Yu Y; Chen Q; Sun C; Shen Y; Tu J; Xiong Y
Nanomedicine; 2020 Oct; 29():102252. PubMed ID: 32615336
[TBL] [Abstract][Full Text] [Related]
12. Fighting against drug-resistant tumors by the inhibition of γ-glutamyl transferase with supramolecular platinum prodrug nano-assemblies.
Wang L; Liu Z; He S; He S; Wang Y
J Mater Chem B; 2021 Jun; 9(22):4587-4595. PubMed ID: 34059856
[TBL] [Abstract][Full Text] [Related]
13. A sulfhydryl blocking reagent BT-4 sensitizes cisplatin-based micelle prodrugs for efficient treatment of breast cancer.
Lin C; Chen Y; Zhu M; Pei J; Zhou Y; Gou M; Ouyang L
Int J Pharm; 2022 Oct; 626():122187. PubMed ID: 36100145
[TBL] [Abstract][Full Text] [Related]
14. Photoinduced Reduction of Novel Dual-Action Riboplatin Pt(IV) Prodrug.
Krasnovskaya OO; Akasov RA; Spector DV; Pavlov KG; Bubley AA; Kuzmin VA; Kostyukov AA; Khaydukov EV; Lopatukhina EV; Semkina AS; Vlasova KY; Sypalov SA; Erofeev AS; Gorelkin PV; Vaneev AN; Nikitina VN; Skvortsov DA; Ipatova DA; Mazur DM; Zyk NV; Sakharov DA; Majouga AG; Beloglazkina EK
ACS Appl Mater Interfaces; 2023 Mar; 15(10):12882-12894. PubMed ID: 36854172
[TBL] [Abstract][Full Text] [Related]
15. Near Infrared-Activatable Platinum-Decorated Gold Nanostars for Synergistic Photothermal/Ferroptotic Therapy in Combating Cancer Drug Resistance.
Del Valle AC; Yeh CK; Huang YF
Adv Healthc Mater; 2020 Oct; 9(20):e2000864. PubMed ID: 32945131
[TBL] [Abstract][Full Text] [Related]
16. A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy.
Chen Y; Yao Z; Liu P; Hu Q; Huang Y; Ping L; Zhang F; Tang H; Wan T; Ping Y; Li B
Acta Biomater; 2023 Mar; 159():275-288. PubMed ID: 36709836
[TBL] [Abstract][Full Text] [Related]
17. Alantolactone-Loaded Pegylated Prodrug Nanocarriers for Synergistic Treatment of Cisplatin-Resistant Ovarian Cancer via Reactivating Mitochondrial Apoptotic Pathway.
Luo Z; Luo Y; Liang X; Lyu Q; Meng F; Chen X; Wang Y; Fang W; Li A; Zhou D
ACS Biomater Sci Eng; 2022 Jun; 8(6):2526-2536. PubMed ID: 35612599
[TBL] [Abstract][Full Text] [Related]
18. An iron oxyhydroxide-based nanosystem sensitizes ferroptosis by a "Three-Pronged" strategy in breast cancer stem cells.
Wu K; Zhang W; Chen H; Wu J; Wang X; Yang X; Liang XJ; Zhang J; Liu D
Acta Biomater; 2023 Apr; 160():281-296. PubMed ID: 36822484
[TBL] [Abstract][Full Text] [Related]
19. Synergistic anticancer activity of triptolide combined with cisplatin enhances apoptosis in gastric cancer in vitro and in vivo.
Li CJ; Chu CY; Huang LH; Wang MH; Sheu LF; Yeh JI; Hsu HY
Cancer Lett; 2012 Jun; 319(2):203-213. PubMed ID: 22306340
[TBL] [Abstract][Full Text] [Related]
20. Co-delivery of IL-12 cytokine gene and cisplatin prodrug by a polymetformin-conjugated nanosystem for lung cancer chemo-gene treatment through chemotherapy sensitization and tumor microenvironment modulation.
Sun Y; Yang J; Yang T; Li Y; Zhu R; Hou Y; Liu Y
Acta Biomater; 2021 Jul; 128():447-461. PubMed ID: 33894351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]